Article
Understanding the drug resistance mechanism of hepatitis C virus NS5B to PF-00868554 due to mutations of the 423 site: a computational study.
Molecular bioSystems - 1 Apr 2014
Jiao Pingzu, Xue Weiwei, Shen Yulin, Jin Nengzhi, Liu Huanxiang
Abstract excerpt
NS5B, a hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) that plays a key role in viral replication, is an important target in the discovery of antiviral agents. PF-00868554 is a potent non-nucleoside inhibitor (NNI) that binds to the Thumb II allosteric pocket of NS5B polymerase and has shown significant promise in phase II clinical trials. Unfortunately, several PF-00868554 resistant mutants have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
